Table 1. Prevalence, location, and size of polyps according to histology.
Histology | Subjects (% n=220) | Number (n=258) |
Location (%) |
Size (%) |
|||
---|---|---|---|---|---|---|---|
Proximal | Distal | ≤5 mm | 6–9 mm | ≥10 mm | |||
Hyperplastic | 45 (4.5) | 68 | 29 (42) | 39 (58) | 61 (89.8) | 6 (8.8) | 1 (1.4) |
MVHP | 20 (2.0) | 28 | 10 (36) | 18 (64) | 22 (78.6) | 5 (17.8) | 1 (3.6) |
GCHP | 25 (2.5) | 40 | 19 (45) | 21 (55) | 38 (95) | 2 (5) | 0 |
SSA/P | 23 (2.3) | 28 | 16 (63.6) | 12 (36.4) | 21 (75) | 6 (21.4) | 1 (3.6) |
TSA | 5 (0.5) | 6 | 2 (25) | 4 (75) | 2 (33.3) | 3 (50) | 1 (16.7) |
Adenoma | 146 (14.8) | 155 | 66 (42.5) | 89 (57.5) | 103 (66.5) | 34 (21.9) | 18 (11.6) |
Tubular | 116 (11.8) | 125 | 56 (44.8) | 69 (55.2) | 93 (74.4) | 24 (19.2) | 8 (6.4) |
Tubulovillous | 28 (2.8) | 28 | 8 (28.6) | 20 (71.4) | 10 (35.8) | 9 (32.1) | 9 (32.1) |
Villous | 2 (0.2) | 2 | 1 (50) | 1 (50) | 0 | 1 (50) | 1 (50) |
Hamartomatous | 1 (0.1) | 1 | 0 | 1 (100) | 1 (100) | 0 | 0 |
GCHP, goblet cells hyperplastic polyp; MVHP, microvescicular hyperplastic polyp; SSA/P, sessile serrated adenoma/polyp; TSA, traditional serrated adenoma.